ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 246

Development and Validation of a Flourescence Optical Imaging Rheumatoid Arthritis Scoring System for Synovitis in the Wrist and Hand

Mads Ammitzbøll-Danielsen1, Mikkel Østergaard1,2, Lene Terslev3, Sarah Ohrndorf4 and Daniel Glinatsi1, 1Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 2Center for Rheumatology and Spine Diseases, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 3Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Copenhagen, Denmark, 4Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Imaging, imaging techniques and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose : To assess the intra- and inter-reader agreement and responsiveness of a novel scoring system for FOI-assessed synovitis.

Methods: FOI of were obtained of both wrists and hands of 46 RA patients inducing or escalating anti-rheumatic therapy and who had ≥1 clinically swollen joint in the hand at baseline, after 3 and 6 months’ follow-up. The hands were placed in the FOI-unit and the patient received a bolus of i.v. ICG-Pulsion (1mg/kg body weight) 10 seconds after starting the examination, which obtained 1 image/second over 6 minutes. The image-sets were anonymized and randomized and were assessed for synovial pathology at the wrist, 1st-5th metacarpophalangeal (MCP), 1st interphalangeal (IP) and 2nd-4th proximal interphalangeal (PIP) joint levels in both hands by two readers blinded to patient data but not chronology. The readers performed a calibration session before the exercise. The images of 23 patients were re-anonymized and were assessed as an intra-reader analysis. The scoring system for synovitis was based on the theory that inflamed tissue would demonstrate a more rapid enhancement than surrounding tissues. For each joint, the images were assessed sequentially from start of injection of ICG-Pulsion to peak enhancement. Synovial pathology was defined as a sharply margined enhancement with clear integrity from surrounding tissues and correct anatomical location lasting ≥3 seconds. The thickness of the pathology fulfilling these criteria were measured in the transverse plane of the hand at the 3rd second of enhancement and were scored as follows: 0: no enhancement, 1: ˂1/3, 2: ≥1/3 but ˂2/3, 3: ≥2/3 of joint thickness. Descriptive statistics and the Wilcoxon signed-rank test were used to assess change in score over time. Intra-/inter-reader for status and change scores were assessed using single measure intra-class correlation coefficients (ICC) and smallest detectable change (SDC, change scores only). Responsiveness was assessed using standardized response mean (SRM).

Results: The median (IQR) change in total synovitis score between baseline and 3/6 months’ follow-up were -5.0 (-10.0;-1.0)/-8.0 (-13.5;-3.0) (p<0.01). Intra- and inter-reader ICC were good to very good for status and change scores at all joint levels and for total scores (Table 1). The SDC were generally low and for the inter-reader SDC, 56%/60% of the patients had a change larger than the SDC between baseline and 3/6 months respectively. The mean SRM for total change scores between baseline and 3/6 months’ follow-up were moderate to good (0.7/0.8).

Conclusion: The novel FOI RA synovitis scoring system showed high reliability and moderate to good responsiveness in the hands. Future studies should focus on comparing the sensitivity and specificity of FOI with ultrasound and magnetic resonance imaging.

Table 1

Baseline

3 months’ follow-up

6 months’ follow-up

ΔBaseline – 3 months

ΔBaseline – 6 months

Intra-reader ICC (SDC), reader 1

Total scores

0.90

0.86

0.83

0.87 (6.2)

0.92 (4.9)

Wrist

0.82

0.92

0.62

0.88 (1.4)

0.91 (1.4)

MCP joints

0.86

0.72

0.93

0.76 (4.8)

0.85 (3.6)

PIP joints

0.95

0.96

0.86

0.90 (2.9)

0.90 (3.3)

Intra-reader ICC (SDC), reader 2

Total scores

0.85

0.72

0.16

0.77

0.74

Wrist

0.84

0.77

0.71

0.80

0.78

MCP joints

0.84

0.67

0.47

0.87

0.84

PIP joints

0.94

0.73

0.24

0.73

0.68

Inter-reader ICC (SDC)

Total scores

0.88

0.84

0.60

0.80 (4.8)

0.70 (6.2)

Wrist

0.76

0.72

0.58

0.67 (1.1)

0.65 (1.3)

MCP joints

0.86

0.80

0.76

0.81 (3.1)

0.66 (3.7)

PIP joints

0.91

0.82

0.39

0.79 (2.6)

0.71 (3.6)


Disclosure: M. Ammitzbøll-Danielsen, None; M. Østergaard, AbbVie, BMS, Celgene, Crescendo Bioscience, Janssen, Merck, 2,Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Centocor, GSK, Hospira, Janssen, Merck, Novartis, Orion, Pfizer, Regeneron, Roche, Takeda, and UCB, 8; L. Terslev, None; S. Ohrndorf, None; D. Glinatsi, None.

To cite this abstract in AMA style:

Ammitzbøll-Danielsen M, Østergaard M, Terslev L, Ohrndorf S, Glinatsi D. Development and Validation of a Flourescence Optical Imaging Rheumatoid Arthritis Scoring System for Synovitis in the Wrist and Hand [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/development-and-validation-of-a-flourescence-optical-imaging-rheumatoid-arthritis-scoring-system-for-synovitis-in-the-wrist-and-hand/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-validation-of-a-flourescence-optical-imaging-rheumatoid-arthritis-scoring-system-for-synovitis-in-the-wrist-and-hand/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology